Boston, MA
Ginkgo Bioworks is a biotech company from the United States founded in 2009 by scientists from MIT and headed by Tom Knight. The company specializes in using genetic engineering to produce bacteria with industrial applications. Ginkgo Bioworks is an analytics company that designs organisms for customers in a range of industries. It is the self-proclaimed "Organism Company" and is one of the world's largest privately held biotech companies. As of 2019, it was valued at $4.2 billion.
https://www.ginkgobioworks.com/These are collections Ginkgo Bioworks is a part of. Click on the collection name to view similar companies.
IPO
Unknown
Post Ipo Equity
$775,000,000
Series F
$70,000,000
Series E
$290,000,000
Series D
$275,000,000
Series C
$100,000,000
Series B
$53,328,100
Series A
$9,000,000
Grant
$179,999
Seed
$1,000,000
Grant
$400,000
Grant
$1,314,964
Grant
$180,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ginkgo Bioworks.